Your browser doesn't support javascript.
loading
Exploiting the antithrombotic effect of the (pro)thrombin inhibitor bothrojaracin.
Assafim, Mariane; Frattani, Flávia S; Ferreira, Marcos S; Silva, Dione M; Monteiro, Robson Q; Zingali, Russolina B.
Affiliation
  • Assafim M; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Frattani FS; Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Ferreira MS; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Silva DM; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Monteiro RQ; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Zingali RB; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: lzingali@bioqmed.ufrj.br.
Toxicon ; 119: 46-51, 2016 Sep 01.
Article in En | MEDLINE | ID: mdl-27179421
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prothrombin / Antithrombins / Crotalid Venoms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Toxicon Year: 2016 Document type: Article Affiliation country: Brazil Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prothrombin / Antithrombins / Crotalid Venoms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Toxicon Year: 2016 Document type: Article Affiliation country: Brazil Country of publication: United kingdom